reference/33066811

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/33066811

Outgoing Links

Predicate	Object
contentType	Journal Article
endingPage	109
issn	0304-3835
pageRange	100-109
publicationName	Cancer Letters
startingPage	100
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_19961e2c4825cb57984d84c75e12597c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b10b0a17599051b1f6a21676dd044bf8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e0a4014146dadb14a3b62cbd9c2429d8 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_487baf6554eb36bb22c6138d90a7c50f http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b15211248ad51cb3cf3292f3fbfefe19 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_cb15e0ef71772c4e3599be8ea2b7f200 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c5084e60391e6499baa00efe44a0801d http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0352fa9dbf5677f98c9a97bb83d9d515
bibliographicCitation	Zhang WJ, Li Y, Wei MN, Chen Y, Qiu JG, Jiang QW, Yang Y, Zheng DW, Qin WM, Huang JR, Wang K, Zhang WJ, Wang YJ, Yang DH, Chen ZS, Shi Z. Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer. Cancer Lett. 2017 Feb 01;386():100–9. doi: 10.1016/j.canlet.2016.11.011. PMID: 27864115.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_20371442c972add6a5899b6df5a464e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4b0f03d358db033f02415727040ab079 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3f392b9f430609adb8eb55f546df685b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_510e5eaf951f91ea47f21e34917ed353 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0003-3462-6055 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9e70de81664aed36f3069cea10230564 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_affd9bb057696a1fa3c7bf88dd2c1269 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddba58cf5047b7ec59c04beb119f6860 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4fadd1f3c46a0ea64812ee4dc07ab633 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_70053a1e219cfdcb677172cba9f3f588 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_126e3bf29bb96041406b3724dd297a33 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05ab68ca78593ddde66f67749c4fc56b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9c2fb87e194868d82ea165a7e5d98873 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f34bc74bade86aac6828bce2bb68c2d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0413d45787c570b3ce74ba39b279d647 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_645bd5c7c983695f685c121707d165d3
date	2017-02-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1016/j.canlet.2016.11.011 https://pubmed.ncbi.nlm.nih.gov/27864115
isPartOf	https://portal.issn.org/resource/ISSN/0304-3835 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/2780
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Synergistic antitumor activity of regorafenib and lapatinib in preclinical models of human colorectal cancer
discusses	http://id.nlm.nih.gov/mesh/M0016578 http://id.nlm.nih.gov/mesh/M0558795 http://id.nlm.nih.gov/mesh/M0473129 http://id.nlm.nih.gov/mesh/M0018233 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0328153 http://id.nlm.nih.gov/mesh/M0018336
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D015179Q000188 http://id.nlm.nih.gov/mesh/D010671Q000494 http://id.nlm.nih.gov/mesh/D020533Q000494 http://id.nlm.nih.gov/mesh/D000971Q000494 http://id.nlm.nih.gov/mesh/D011725Q000494 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D011799Q000494
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D011725Q000493 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D015179Q000473 http://id.nlm.nih.gov/mesh/D020533Q000493 http://id.nlm.nih.gov/mesh/D023041 http://id.nlm.nih.gov/mesh/D049109Q000187 http://id.nlm.nih.gov/mesh/D015179Q000097 http://id.nlm.nih.gov/mesh/D004305 http://id.nlm.nih.gov/mesh/D009389 http://id.nlm.nih.gov/mesh/D017209Q000187 http://id.nlm.nih.gov/mesh/D059447Q000187 http://id.nlm.nih.gov/mesh/D058990 http://id.nlm.nih.gov/mesh/D010671Q000493 http://id.nlm.nih.gov/mesh/D020128 http://id.nlm.nih.gov/mesh/D019073 http://id.nlm.nih.gov/mesh/D000077341 http://id.nlm.nih.gov/mesh/D011799Q000493 http://id.nlm.nih.gov/mesh/D008807 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D047368Q000187 http://id.nlm.nih.gov/mesh/D045325 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D047428Q000493 http://id.nlm.nih.gov/mesh/D000971Q000493 http://id.nlm.nih.gov/mesh/D004357
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11167602 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID208908

Total number of triples: 84.